Accelrys enhances drug discovery software

Accelrys is expanding its Discovery Studio software with improved life science modeling and simulation functionality. The new software includes pharmacophore modeling and Perl scripting. Report

Suggested Articles

UPMC researchers are planning clinical trials of a COVID-19 vaccine that uses pieces of the virus' spike protein to create immunity.

Treating mice with niacin increased the number of immune cells in glioblastomas, reducing tumor size and extending survival.

Efforts to pivot existing discoveries into COVID-19 cures may not bear fruit until the pandemic has ended but could help fend off future outbreaks.